Arax Advisory Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
22,757
+10,860
+91% +$551K 0.01% 1148
2026
Q1
$635K Sell
11,897
-2,332
-16% -$137K 0.02% 557
2025
Q4
$884K Buy
+14,229
New +$878K 0.03% 416
2025
Q3
Sell
-13,215
Closed -$845K 3937
2025
Q2
$845K Buy
13,215
+595
+5% +$35.8K 0.04% 277
2025
Q1
$760K Buy
12,620
+10,714
+562% +$665K 0.05% 229
2024
Q4
$111K Buy
1,906
+1,048
+122% +$62.3K 0.01% 651
2024
Q3
$50.8K Hold
858
﹤0.01% 714
2024
Q2
$48.1K Buy
+858
New +$48K ﹤0.01% 676

Other funds holding IHI

Arax Advisory Partners's IHI Position: Q2 2026 in Review

Arax Advisory Partners increased its iShares US Medical Devices ETF (IHI) stake by 91% in Q2 2026, buying an estimated $551K and bringing the position to 22,757 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1148.

Arax Advisory Partners first reported a position in IHI in Q2 2024 and has held it in 8 quarters since. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Arax Advisory Partners held 22,757 shares of iShares US Medical Devices ETF worth $1.12M as of Q2 2026.
  • Arax Advisory Partners bought 10,860 iShares US Medical Devices ETF shares in Q2 2026, an estimated $551K.
  • iShares US Medical Devices ETF made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1148 holding.
  • Arax Advisory Partners first reported a position in iShares US Medical Devices ETF in Q2 2024 and has held it in 8 quarters since.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.